Order Article Reprints

Cesaro A, Acerbo V, Vetrano E, Signore G, Scherillo G, Rotolo FP, De Michele G, Scialla F, Raucci G, Panico D, et al. Sodium–Glucose Cotransporter 2 Inhibitors in Patients with Diabetes and Coronary Artery Disease: Translating the Benefits of the Molecular Mechanisms of Gliflozins into Clinical Practice. International Journal of Molecular Sciences. 2023; 24(9):8099. https://doi.org/10.3390/ijms24098099

Cesaro, Arturo, Vincenzo Acerbo, Erica Vetrano, Giovanni Signore, Gianmaria Scherillo, Francesco Paolo Rotolo, Gianantonio De Michele, Francesco Scialla, Giuseppe Raucci, Domenico Panico, and et al. 2023. "Sodium–Glucose Cotransporter 2 Inhibitors in Patients with Diabetes and Coronary Artery Disease: Translating the Benefits of the Molecular Mechanisms of Gliflozins into Clinical Practice" International Journal of Molecular Sciences 24, no. 9: 8099. https://doi.org/10.3390/ijms24098099

Cesaro, A., Acerbo, V., Vetrano, E., Signore, G., Scherillo, G., Rotolo, F. P., De Michele, G., Scialla, F., Raucci, G., Panico, D., Gragnano, F., Moscarella, E., Galiero, R., Caturano, A., Ruggiero, R., Sasso, F. C., & Calabrò, P. (2023). Sodium–Glucose Cotransporter 2 Inhibitors in Patients with Diabetes and Coronary Artery Disease: Translating the Benefits of the Molecular Mechanisms of Gliflozins into Clinical Practice. International Journal of Molecular Sciences, 24(9), 8099. https://doi.org/10.3390/ijms24098099